Litcius/Paper detail

Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas

Evan C. Cumpston, Steven D. Rhodes, Charles W. Yates

2023Current Oncology Reports12 citationsDOI

Topics & Concepts

MedicineVestibular SchwannomasNeurofibromatosis type 2Targeted therapyNeurofibromatosisVestibular systemInternal medicineAudiologyPathologyCancerNeurofibromatosis and Schwannoma CasesMeningioma and schwannoma managementBone Tumor Diagnosis and Treatments
Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas | Litcius